SEC Form 4 · accession 0000899243-16-011143
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nader Pourhassan
Officer — President and CEO · Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 6, 2016 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (right to buy)F1 | $0.75 | Jan 4, 2016 | A | 304,000 | A | — | Jan 4, 2026 | Common Stock | 304,000 | 304,000 | D |
Explanation of responses
- F1The options vest upon the achievement of certain strategic milestones specified in the award agreement.